SCHEMBL844676

SCHEMBL844676

CC(=O)c1ccc(-c2ccc3[nH]c4c(ccc5cc[nH]c54)c3c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 2/20 0.56
KIF11 P52732 2/20 0.43
MAOA P21397 1/20 0.41
PTGS2 P35354 1/20 0.38
HSD17B1 P14061 2/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CDK2 P24941 3/20 0.36
PLK4 O00444 1/20 0.36
DCLK1 O15075 1/20 0.36
ROCK2 O75116 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
PAK4 O96013 1/20 0.36
CHEK2 O96017 1/20 0.36
INSR P06213 1/20 0.36
CDK1 P06493 1/20 0.36
FES P07332 1/20 0.36
ROS1 P08922 1/20 0.36
PDGFRB P09619 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12234734 0.82 PIM3 (0.62) PIM3KIF11MAPTSMN1; SMN2CDK2
SCHEMBL844942 0.81 PIM3 (0.64) PIM3KIF11CDK2CLK2CDK5
SCHEMBL844971 0.81 PIM3 (0.64) PIM3KIF11CDK2CLK2CDK5
SCHEMBL844580 0.80 PIM3 (0.62) PIM3KIF11CDK2CCNE2CDK4
SCHEMBL844541 0.76 PIM3 (0.58) PIM3KIF11HSD17B10
SCHEMBL5661439 0.76 KDM4E (0.57) MAOAPTGS2HSD17B1MAPTSMN1; SMN2
SCHEMBL19391065 0.76 PTGS2 (0.60) MAOAPTGS2HSD17B1MAPTSMN1; SMN2
SCHEMBL31574489 0.76 PTGS2 (0.60) MAOAPTGS2HSD17B1MAPTSMN1; SMN2
SCHEMBL844301 0.75 PIM3 (0.53) PIM3MAPTCDK2CCNE2CDK4
SCHEMBL844827 0.73 PIM3 (0.54) PIM3KIF11CDK2ROCK2PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US claimed
EP-2326649-B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP claimed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US claimed
JP-2011526610-A 2011-10-13 JP claimed
EP-2326649-A1 NOVEL PYRROLO Ý2,3-A¨CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS Centre National de la Recherche Scientifique (FR) 2011-06-01 EP claimed
WO-2010000978-A1 NOVEL PYRROLO [2,3-A] CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-01-07 WO claimed
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US disclosed
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US disclosed
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US disclosed
EP-2326649-B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP disclosed
EP-2326649-B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP disclosed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US disclosed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US disclosed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US disclosed
WO-2010000978-A1 NOVEL PYRROLO [2,3-A] CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors PIM3, PIM1, PIM2 PIM3 1/4885KIF11 1961/4885MAOA 2720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.